EDVANYSEBeveragesFiscal year ends December 31
Endovia Health Sciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026
$0.14−0.01 (-7.53%)
Close on Oct 19, 2026
- Market cap
- $413.76K
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0.0%
0M of 6M shares
Institutional holders
1
1 new, 0 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Yorke Justin W | 907,979 | 28.60% | 13D (active) | Jul 31, 2025 |
| Caple Frederick William | 767,500 | 24.10% | 13D (active) | Jul 31, 2025 |
| Meissner William R. | 752,500 | 23.80% | 13D (active) | Jul 31, 2025 |
| Fore Thomas Butler | 750,000 | 23.70% | 13D (active) | Jul 31, 2025 |
| Tong Magdalene | 200,000 | 7.70% | 13G (passive) | Jul 31, 2025 |
| Nistico Robert | 180,470 | 7.10% | 13D (active) | Jul 31, 2025 |
| Aida Aragon | 150,000 | 5.80% | 13G (passive) | Jul 31, 2025 |
| Devereux William T | 1,005,000 | 29.40% | 13D (active) | Jul 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of EDVA | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Harbour Investments, Inc. | 470 | 0.01% | $73 | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | 0M | 0.0% | 1 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Brady James Cobb | Interim CEO, Director | – | – | Jun 10, 2026 |
| Robert Nistico | CEO and Chairman, Director, 10% owner | 38,053 | 0.59% | Oct 15, 2025 |
| Michael Breen Bondurant | Chief Operating Officer | – | – | Jun 18, 2026 |
| Martin P. Scott | Interim CFO | – | – | Jun 10, 2026 |
| William T. Devereux | Chief Financial Officer | – | – | Oct 15, 2025 |
| William R. Meissner | President and CMO, 10% owner | – | – | Oct 14, 2025 |
| Frederick William Caple | Director | 1,875 | 0.03% | Jun 10, 2026 |
| Thomas Butler Fore | Director | – | – | Jun 10, 2026 |
| Knuettel Francis II | Director | 30,000 | 0.47% | Jun 10, 2026 |
| Justin W. Yorke | Director | 19,151,440 | 298.66% | Oct 15, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Frederick William Caple Director | Apr 19, 2024 | Award | +1,875 | – | – | 1,875 |
| Robert Nistico CEO and Chairman, Director | Mar 5, 2024 | Award | +4,000 | – | – | 38,053 |
| Robert Nistico CEO and Chairman, Director | Jun 16, 2023 | Buy | +7,000 | $1.01 | $7.07K | 1,386,000 |
| Robert Nistico CEO and Chairman, Director | Apr 14, 2023 | Buy | +12,000 | $1.15 | $13.80K | 1,379,000 |
| Robert Nistico CEO and Chairman, Director | Apr 13, 2023 | Buy | +7,000 | $1.17 | $8.19K | 1,357,000 |
| Robert Nistico CEO and Chairman, Director | Apr 13, 2023 | Buy | +10,000 | $1.17 | $11.70K | 1,367,000 |
| Robert Nistico CEO and Chairman, Director | Jun 16, 2022 | Buy | +1,000 | $1.69 | $1.69K | 1,327,070 |
| Robert Nistico CEO and Chairman, Director | Jun 16, 2022 | Buy | +1,000 | $1.67 | $1.67K | 1,326,070 |
| Robert Nistico CEO and Chairman, Director | Jun 16, 2022 | Buy | +1,000 | $1.69 | $1.69K | 1,325,070 |
| Robert Nistico CEO and Chairman, Director | Jun 15, 2022 | Buy | +315 | $1.82 | $573 | 1,323,385 |
| Robert Nistico CEO and Chairman, Director | Jun 15, 2022 | Buy | +685 | $1.83 | $1.25K | 1,324,070 |
| Robert Nistico CEO and Chairman, Director | Jun 3, 2022 | Buy | +1,000 | $2.07 | $2.07K | 1,323,070 |
| Robert Nistico CEO and Chairman, Director | Jun 3, 2022 | Buy | +1,000 | $2.04 | $2.04K | 1,322,070 |
| Robert Nistico CEO and Chairman, Director | May 27, 2022 | Buy | +2,000 | $2.12 | $4.24K | 1,319,070 |
| Robert Nistico CEO and Chairman, Director | May 27, 2022 | Buy | +1,000 | $2.03 | $2.03K | 1,320,070 |
| Robert Nistico CEO and Chairman, Director | May 27, 2022 | Buy | +1,000 | $2.04 | $2.04K | 1,321,070 |
| Robert Nistico CEO and Chairman, Director | May 26, 2022 | Buy | +2,000 | $1.95 | $3.90K | 1,317,070 |
| Robert Nistico CEO and Chairman, Director | May 26, 2022 | Buy | +2,000 | $1.95 | $3.90K | 1,315,070 |
| Robert Nistico CEO and Chairman, Director | May 26, 2022 | Buy | +2,000 | $1.99 | $3.98K | 1,313,070 |
| Robert Nistico CEO and Chairman, Director | May 26, 2022 | Buy | +1,000 | $1.94 | $1.94K | 1,311,070 |
| Dean Scott Huge Chief Financial Officer | Oct 16, 2020 | Award | +140,000 | $0.75 | $105.00K | 727,315 |
| Michael J. West Director | Jun 21, 2019 | Sale | −8,000,000 | $0.03 | $240.00K | 344,000 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.